2 completed, 1 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
Follow Aftercare: new trials by email Literature Review of Aftercare trials Research Report on Aftercare
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects PB2452 Infusion, Placebo - Sodium Chloride, Ticagrelor Oral Tablet - Pre-Treatment - Healthy | Phase 2 | Completed | SFJ Pharmaceuticals, Inc. | 23 | 2019-04-16 | 2024-05-01 |
| Polaris Oncology Survivor Transition (POST) System POST Intervention, POST Treatment as Usual - Cancer | Phase 2 | Completed | Polaris Health Directions | 200 | 2016-11-30 | 2019-11-26 |
| Follow-up After Metastasectomy in Patients With Kidney Cancer Follow-Up Care, Laboratory Biomarker Analysis - Renal Cell Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 86 | 2009-06-09 | 2026-10-06 |
Carcinoma, Renal Cell (1) · Neoplasms (1)
M.D. Anderson Cancer Center (1) · Polaris Health Directions (1) · SFJ Pharmaceuticals, Inc. (1)
United States (3)
Eric Jonasch (1) · Erin O'Hea, PhD (1) · LuAnn Bundrant, MD (1)